|
CALCOCO1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23709999969124E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.11849999987024E-07 |
| Normal-vs-Stage2 |
1.945600E-01 |
| Normal-vs-Stage3 |
1.169720E-04 |
| Normal-vs-Stage4 |
1.220610E-04 |
| Stage1-vs-Stage2 |
4.941900E-02 |
| Stage1-vs-Stage3 |
6.041600E-01 |
| Stage1-vs-Stage4 |
7.432400E-01 |
| Stage2-vs-Stage3 |
1.385010E-01 |
| Stage2-vs-Stage4 |
6.891600E-02 |
| Stage3-vs-Stage4 |
4.895000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.65950000197546E-08 |
| Normal-vs-AfricanAmerican |
1.500750E-03 |
| Normal-vs-Asian |
1.69767000000043E-05 |
| Caucasian-vs-AfricanAmerican |
4.968200E-01 |
| Caucasian-vs-Asian |
2.366200E-01 |
| AfricanAmerican-vs-Asian |
8.566000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.184430E-04 |
| Normal-vs-Female |
2.43949999978454E-07 |
| Male-vs-Female |
5.367000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.6317000052839E-08 |
| Normal-vs-Age(41-60Yrs) |
1.24060000050719E-07 |
| Normal-vs-Age(61-80Yrs) |
5.422500E-02 |
| Normal-vs-Age(81-100Yrs) |
7.119600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.334800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.196000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.612200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.240200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.674350E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.962000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.280800E-01 |
| Classical-VS-Follicular |
9.63817914367837E-12 |
| Classical-VS-Other |
2.040200E-01 |
| Classical-VS-Normal |
8.07950373271638E-11 |
| Tall-VS-Follicular |
5.980500E-04 |
| Tall-VS-Other |
2.640400E-01 |
| Tall-VS-Normal |
3.218600E-04 |
| Follicular-VS-Other |
3.406200E-01 |
| Follicular-VS-Normal |
6.108400E-01 |
| Other-VS-Normal |
2.243000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.184100E-04 |
| Normal-vs-N1 |
2.919300E-03 |
| N0-vs-N1 |
4.675600E-01 |
|
|
